Research Article

Cross-Section Calculations of Medical Radioisotope 64Cu via some Proton, Neutron and Deuteron Reactions

Volume: 44 Number: 3 September 29, 2023
EN

Cross-Section Calculations of Medical Radioisotope 64Cu via some Proton, Neutron and Deuteron Reactions

Abstract

The Copper-64 radioisotope, whose academic research continues on diagnostic and therapeutic use, was examined in this study. 64Cu radioisotope is unique among other Cu isotopes for medical usage due to its low positron energy, appropriate half-life, and short tissue penetration. In cases where experimental data are missing, cross-section calculations can be used, and the existence of the cross-section data may provide various advantages in managing time, cost, and efficiency. In this context, investigated detailed cross-section calculations of the 64Cu isotope. To this end, cross-sections acquired from various calculation codes were compared with the literature, and alternative production routes were investigated. Using the nuclear reaction codes TALYS and EMPIRE, cross-section data of the 64Cu isotope were obtained from the 64Ni(p,n)64Cu, 65Cu(p,n+p)64Cu, 68Zn(p,n+α)64Cu, 65Cu(n,2n)64Cu, 64Ni(d,2n)64Cu, and 63Cu(d,p)64Cu reactions with the equilibrium and pre-equilibrium models. The results were compared with the available literature data from the EXFOR database.

Keywords

References

  1. [1] IAEA (International Atomic Energy Agency), IAEA Radioisotopes and Radiopharmaceuticals Reports No. 1; Cyclotron Produced Radionuclides: Emerging Positron Emitters for Medical Applications: 64Cu and 124I, https:// https://www.iaea.org/publications/10791/cyclotron-produced-radionuclides-emerging-positron-emitters-for-medical-applications-64cu-and-124i Retrieved April 4, 2022.
  2. [2] IAEA (International Atomic Energy Agency), Cyclotron Produced Radionuclides: Principles and Practice, Technical Reports Series No. 465, https://www-pub.iaea.org/MTCD/publications/PDF/trs465_web.pdf. Retrieved March 21, 2022.
  3. [3] Gutfilen B., Souza S. A., Valentini G., Copper-64: A Real Theranostic Agent, Drug Des. Devel. Ther., 12 (2018) 3235–3245.
  4. [4] Boschi A., Martini P., Janevik-Ivanovska E., Duatti A., The Emerging Role of Copper-64 Radiopharmaceuticals as Cancer Theranostics, Drug Disc. Today, 23(8) (2018) 1489–1501.
  5. [5] Capriotti G., Piccardo A., Giovannelli E., Signore A., Targeting Copper in Cancer Imaging and Therapy: A New Theragnostic Agent, J Clin Med, 12(1) (2022) 223.
  6. [6] Peng F., Recent Advances in Cancer Imaging with 64CuCl2 PET/CT, Nucl Med Mol Imaging, 56(2) (2022) 80-85.
  7. [7] Jalilian AR., Osso JA Jr., Vera-Araujo J., et al., IAEA Contribution to the Development of 64Cu Radiopharmaceuticals for Theranostic Applications, Q. J. Nucl. Med. Mol. Imaging, 64(4) (2020) 338-345.
  8. [8] Follacchio GA., De Feo MS., De Vincentis G., Monteleone F., Liberatore M., Radiopharmaceuticals Labelled with Copper Radionuclides: Clinical Results in Human Beings, Curr. Radiopharm., 11(1) (2018) 22-33.

Details

Primary Language

English

Subjects

Classical Physics (Other)

Journal Section

Research Article

Publication Date

September 29, 2023

Submission Date

May 1, 2023

Acceptance Date

July 11, 2023

Published in Issue

Year 2023 Volume: 44 Number: 3

APA
Gülümser, T., & Kaplan, A. (2023). Cross-Section Calculations of Medical Radioisotope 64Cu via some Proton, Neutron and Deuteron Reactions. Cumhuriyet Science Journal, 44(3), 583-589. https://doi.org/10.17776/csj.1290957

Cited By

As of 2026, Cumhuriyet Science Journal will be published in six issues per year, released in February, April, June, August, October, and December